Medical device manufacturer welcomed by Newport News innovation hub

NEWPORT NEWS, Va., April 16, 2019 – ivWatch, a medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, announced today the lease signing as the anchor organization of Newport News Tech Center Research Park’s Building One. The company is relocating from its Hampton headquarters and Williamsburg research & development (R&D) facility, combining all departments under one roof.

“The move signifies our ongoing investment in the region and aligns our strong history of medical innovation with this budding business and entrepreneurial community,” said Gary Warren, president and CEO of ivWatch. “The Research Park is the type of space we need to expand our clinical and R&D efforts, execute manufacturing and national and international distribution of our product, all while maintaining essential business functions like operations, sales and marketing.”

As the anchor tenant occupying more than 25,500 sq. ft., the building will include exterior ivWatch signage. The first-floor manufacturing space will be housed within sleek glass walls, and state-of-the-art R&D and office space will be located on the third floor.

The ivWatch move-in is slated to be complete by mid-2019, and a ribbon-cutting for Building One is planned for August 2019.

To learn more about ivWatch, visit To learn more about Tech Center Research Park, visit

About ivWatch:
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians are able to leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit

ivWatch is pleased to sponsor the work of, an online resource dedicated to empowering visitors with information on all things IV, simplified.

MEDIA CONTACT: Amara Betoney,, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest